期刊文献+

HPLC-MS/MS法测定人血浆中氯法拉滨的浓度 被引量:1

Determination of the Concentration of Clofarabine in Human Plasma by HPLC-MS/MS
原文传递
导出
摘要 目的:建立测定人血浆中氯法拉滨浓度的方法。方法:血浆样品经甲基叔丁基醚提取处理后,采用高效液相色谱串联质谱电喷雾(HPLC-MS/MS)法进行测定,色谱柱为Thermo C18,流动相为乙腈-水(250∶3,其中含4 mmol·L-1乙酸铵和0.3%甲酸),流速为0.5 mL·min-1,进样量为10μL,内标为克拉屈滨。用于定量氯法拉滨和克拉屈滨的离子反应分别为m/z 304.2→170.0、m/z286.1→170.0。每个样品的分析时间为5 min。结果:氯法拉滨和克拉屈滨的保留时间分别为3.83、3.90 min。氯法拉滨血药浓度在2.5~500 ng·mL-1范围内线性关系良好(r=0.999 9),日内、日间RSD均<14%,方法回收率为95.64%~99.23%。结论:本方法简便、灵敏、快速、准确,适用于氯法拉滨的血药浓度测定及药动学研究。 OBJECTIVE: To establish a method for the concentration determination of clofarabine in human plasma. METHODS: The plasma samples were extracted with methyl tert-butyl ether, then was determined by HPLC-MS/MS. Thermo C18 column was used as analytic column with mobile phase consisted of acetonitrile-water (250 ∶ 3, containing 4 mmol·L-1 ammonium acetate and 0.3% formic acid) at flow rate of 0.5 mL·min-1. The injection volume was 10 μL and cladribine was used as the internal standard (IS). Clofarabine and cladribine were detected on multiple reaction monitoring (MRM) by the transitions from the precursor to the product ion (m/z 304.2→170.0 and m/z 286.1→170.0). And the total running time was 5 min. RESULTS: The retention time of clofarabine and cladribine were 3.83 min and 3.90 min. The linear range of clofarabine was 2.5~500 ng·mL-1(r=0.999 9). The RSD of intra-day and inter-day were both less than 14% and the average recovery was 95.64%~99.23%. CONCLUSION: Established method is simple, sensitive, rapid and accurate, and it is suitable for plasma concentration determination and pharmacokinetics study of clofarabine.
出处 《中国药房》 CAS CSCD 北大核心 2011年第22期2056-2058,共3页 China Pharmacy
关键词 氯法拉滨 高效液相色谱串联质谱电喷雾法 血药浓度 药动学 Clofarabine HPLC-MS/MS Plasma concentration Pharmacokinetics
  • 相关文献

参考文献8

二级参考文献28

  • 1王蔚,晋展.抗急性白血病新药Clofarabine[J].药学进展,2004,28(7):336-336. 被引量:10
  • 2聂颖兰,傅得兴,胡欣,王唯红.新型抗白血病药氯法拉滨[J].中国新药杂志,2007,16(10):821-824. 被引量:9
  • 3夏敏,蒋慧.儿童急性白血病治疗新药氯法拉滨[J].世界临床药物,2007,28(6):356-359. 被引量:11
  • 4李珂珂,谭丰苹.毛细管气相色谱法测定拉米夫定中有机溶剂的残留量[J].中国药房,2007,18(19):1502-1503. 被引量:15
  • 5Hsieh Y,Duncan CJ, Lee S, et al. Comparison of fast liquid chromatography/ tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma[J] .J Pharma Biomed Anal, 2007, 44(2) : 492.
  • 6JUDITH E K, REBECCA M R, KUMUDHA B, et al. A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias [ J ]. Clin Trials Observations, 2007, 110(6) : 1762 - 1769.
  • 7YUNSHENG H, CHRISTINE J G D, SUINING L. et al. Comparision of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma [J] . J Pharm Biota Anal, 2007, 44(2) : 492 - 497.
  • 8VARSHA G, HAGOP K, STEFAN F, et al. Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias[ J ]. Clin Cancer Res, 2003, 9(12): 6335 -6342.
  • 9国家药典委员会 二部.中华人民共和国药典[S].北京:化学工业出版社,2005.附录.
  • 10FADERL S, GANDHI V, O'BRIEN S, et al. Results of a phase 1-2 study of clofarabine in combination with cytarabine ( ara-C ) in relapsed and refractory acute leukemias [ J ]. Blood, 2005, 105(3) :940-947.

共引文献13

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部